HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.
about
The gut microbiome in human immunodeficiency virus infectionUse of Metatranscriptomics in Microbiome ResearchThe Gut Microbiota and Immune System Relationship in Human Graft-versus-Host DiseaseLocal and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract InfectionsMetagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host MicrobiomeHIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationThe rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and preventionMicrobiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Intestinal microbiota as modulators of the immune systemMicrobial translocation and microbiome dysbiosis in HIV-associated immune activationTranslocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239.Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection.Gut microbiota in 2015: Prevotella in the gut: choose carefully.Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy.Effects of HIV, Immune Deficiency, and Confounding on the Distal Gut MicrobiotaImpact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trialFat Matters: Understanding the Role of Adipose Tissue in Health in HIV InfectionDestabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees.Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population.Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection.Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle.Maternal HIV infection influences the microbiome of HIV-uninfected infants.Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens.Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.The respiratory microbiome of HIV-infected individuals.Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.The gut microbiome and HIV-1 pathogenesis: a two-way street.Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria.Modulation of the orodigestive tract microbiome in HIV-infected patients.The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen.Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.Changes of the Intestinal Microbiome-Host Homeostasis in HIV-Infected Individuals - A Focus on the Bacterial Gut Microbiome.Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.Unraveling Interactions between the Microbiome and the Host Immune System To Decipher Mechanisms of Disease.Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial.Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals.
P2860
Q26743543-C8FE62D4-094A-4F5D-A280-723DD1EFD038Q26749065-081D3A91-8AC1-4B8F-8DB1-D7D973152C3DQ26751265-4DEB9EC6-B2A2-4C80-B40E-7F5599DC3FB2Q26752371-CD132828-4525-4B22-AAA6-02EFE5E47A21Q26779142-4AC6A4A4-9DEC-413E-9DF5-76718CD97918Q30839904-9388873C-F711-4976-821D-199C601BC4D1Q33694217-BC4A48E3-4559-4B10-9042-5E6A4B35C963Q33827624-0AB2D723-F539-46A2-B317-0C7C29E56AD5Q34517656-B7A37621-AD35-437F-A2D1-9BE832085BD8Q35156136-B9E42DF3-B63C-4460-AC5B-F63DBB8E1B7BQ35589732-8B919266-74FC-49AF-877E-AC8065AAD7CFQ35872112-5E00C3B7-3624-46CC-9A0B-CC783CA14B27Q35883609-9AD47691-A2AB-46EB-8E27-59AD20350CB2Q35892944-8DFEDD68-F11F-4500-AB17-C805238E3B07Q35909605-AE421D42-C7D5-4015-85F3-417AF2A0F0F8Q35945416-00CF7FED-0831-4289-9FB0-F2D0716F5AFFQ35989400-422B0612-50B4-4B0E-9EF3-5F7BAEF28729Q36339858-1AF19144-F7D1-4C83-9486-48538D3B4772Q36654972-3C1BA8A3-EE4A-410C-A230-EDF8F53590A4Q37014250-7B62A6DF-F8F6-47A9-9CCB-5933EBA1EAECQ37141323-87ABF6F6-11C1-4BEF-98CD-E67A06162F20Q37317771-9CBAD187-22F6-4A11-A0E3-7ABE7F403ECFQ37574992-201140A4-4622-495E-BC9A-1D32A12F8540Q37635172-308C398E-C76A-486E-95D3-91C059E094A8Q37682227-E9C58998-3850-4FAC-8A99-61B8F6889474Q38727201-0D3770FB-85B8-44D7-A702-5D8485696F20Q38878361-AE44CF03-A231-411F-B638-FD98A06F2282Q38973447-78816CB5-CB71-4C6C-AC65-5EEE86D3ACFCQ38984137-3EB08799-E210-46C4-94DB-C5836A1A0B34Q39001817-E3D5BAC7-AD1E-481F-BF4D-32E9396FE2FAQ39826701-448F3D2D-9B77-4677-BBDA-8EA06BD66F50Q40400842-A649DE00-C1A4-47F3-B48A-8BAA043F4DECQ40567962-0B3FF188-56CB-4FC4-A579-F4D0CD945B94Q42366790-FA34D07E-D646-446B-9481-6054405451E4Q42372824-D6CD5443-C12E-4E71-BF6F-E947532747DAQ46286824-A45449FB-A4DB-41DF-835E-586D2F4D6557Q48091579-B3623FFA-2F69-42E0-8A92-7702A6FEA281Q52725538-5A78C6C7-E943-4963-9F44-FC80CF22E445Q55260772-10B9F3DC-BC05-4948-B50C-724576AAF9EEQ55360165-A3A7ED8A-06B1-4388-972B-D29376DCB0F6
P2860
HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV-induced alteration in gut ...... cts of antiretroviral therapy.
@ast
HIV-induced alteration in gut ...... cts of antiretroviral therapy.
@en
type
label
HIV-induced alteration in gut ...... cts of antiretroviral therapy.
@ast
HIV-induced alteration in gut ...... cts of antiretroviral therapy.
@en
prefLabel
HIV-induced alteration in gut ...... cts of antiretroviral therapy.
@ast
HIV-induced alteration in gut ...... cts of antiretroviral therapy.
@en
P2093
P2860
P356
P1433
P1476
HIV-induced alteration in gut ...... cts of antiretroviral therapy.
@en
P2093
Andrew P Fontenot
Brent E Palmer
Charles P Neff
Matthew E Rhodes
Thomas B Campbell
P2860
P304
P356
10.4161/GMIC.32132
P577
2014-07-31T00:00:00Z